These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 22151825

  • 1. Tissue expression of squamous cellular carcinoma antigen and Ki67 in hepatocellular carcinoma-correlation with prognosis: a historical prospective study.
    Schmilovitz-Weiss H, Tobar A, Halpern M, Levy I, Shabtai E, Ben-Ari Z.
    Diagn Pathol; 2011 Dec 07; 6():121. PubMed ID: 22151825
    [Abstract] [Full Text] [Related]

  • 2. Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma.
    Giannelli G, Marinosci F, Sgarra C, Lupo L, Dentico P, Antonaci S.
    Int J Cancer; 2005 Sep 10; 116(4):579-83. PubMed ID: 15825162
    [Abstract] [Full Text] [Related]

  • 3. Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC.
    Trerotoli P, Fransvea E, Angelotti U, Antonaci G, Lupo L, Mazzocca A, Mangia A, Antonaci S, Giannelli G.
    Mol Cancer; 2009 May 27; 8():29. PubMed ID: 19473531
    [Abstract] [Full Text] [Related]

  • 4. Expression of MTA2 and Ki-67 in hepatocellular carcinoma and their correlation with prognosis.
    Shi W, Hu J, Zhu S, Shen X, Zhang X, Yang C, Gao H, Zhang H.
    Int J Clin Exp Pathol; 2015 May 27; 8(10):13083-9. PubMed ID: 26722504
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC).
    Pozzan C, Cardin R, Piciocchi M, Cazzagon N, Maddalo G, Vanin V, Giacomin A, Pontisso P, Cillo U, Farinati F.
    J Gastroenterol Hepatol; 2014 Aug 27; 29(8):1637-44. PubMed ID: 24635038
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of squamous cell carcinoma antigen 1 is associated with the onset and progression of human hepatocellular carcinoma.
    Liu J, Gao Y, Yang B, Jia X, Zhai D, Li S, Zhang Q, Jing L, Wang Y, Du Z, Wang Y.
    Arch Med Res; 2015 Feb 27; 46(2):133-41. PubMed ID: 25819271
    [Abstract] [Full Text] [Related]

  • 7. Circulating SCCA-IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients.
    Guarino M, Di Costanzo GG, Gallotta A, Tortora R, Paneghetti L, Auriemma F, Tuccillo C, Fassina G, Caporaso N, Morisco F.
    Scand J Clin Lab Invest; 2017 Oct 27; 77(6):448-453. PubMed ID: 28609160
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients.
    Hussein MM, Ibrahim AA, Abdella HM, Montasser IF, Hassan MI.
    Indian J Cancer; 2008 Oct 27; 45(4):167-72. PubMed ID: 19112206
    [Abstract] [Full Text] [Related]

  • 9. Squamous cell carcinoma antigen in human liver carcinogenesis.
    Guido M, Roskams T, Pontisso P, Fassan M, Thung SN, Giacomelli L, Sergio A, Farinati F, Cillo U, Rugge M.
    J Clin Pathol; 2008 Apr 27; 61(4):445-7. PubMed ID: 17893121
    [Abstract] [Full Text] [Related]

  • 10. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G, Chen JH, Qiang Y, Wang DZ, Chen Z.
    World J Gastroenterol; 2015 Apr 07; 21(13):3983-93. PubMed ID: 25852285
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysis.
    Liu CH, Gil-Gómez A, Ampuero J, Romero-Gómez M.
    Liver Int; 2018 Oct 07; 38(10):1820-1831. PubMed ID: 29704434
    [Abstract] [Full Text] [Related]

  • 12. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma.
    Beneduce L, Castaldi F, Marino M, Quarta S, Ruvoletto M, Benvegnù L, Calabrese F, Gatta A, Pontisso P, Fassina G.
    Cancer; 2005 Jun 15; 103(12):2558-65. PubMed ID: 15887222
    [Abstract] [Full Text] [Related]

  • 13. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
    Zhu PP, Yuan SG, Liao Y, Qin LL, Liao WJ.
    World J Gastroenterol; 2015 Jun 21; 21(23):7254-63. PubMed ID: 26109813
    [Abstract] [Full Text] [Related]

  • 14. Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma.
    Yang X, Ni H, Lu Z, Zhang J, Zhang Q, Ning S, Qi L, Xiang B.
    BMC Cancer; 2023 Jan 05; 23(1):10. PubMed ID: 36600214
    [Abstract] [Full Text] [Related]

  • 15. AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.
    Beale G, Chattopadhyay D, Gray J, Stewart S, Hudson M, Day C, Trerotoli P, Giannelli G, Manas D, Reeves H.
    BMC Cancer; 2008 Jul 18; 8():200. PubMed ID: 18638391
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma.
    Pontisso P, Calabrese F, Benvegnù L, Lise M, Belluco C, Ruvoletto MG, Marino M, Valente M, Nitti D, Gatta A, Fassina G.
    Br J Cancer; 2004 Feb 23; 90(4):833-7. PubMed ID: 14970861
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C, Wu M, Zong G, Wan C, Liu Q, Zhou H, Hua L, Chen Y, Chen X, Lu C.
    Dig Dis Sci; 2017 Jan 23; 62(1):133-142. PubMed ID: 27921263
    [Abstract] [Full Text] [Related]

  • 18. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL, Sun J, Lai JJ, Jiang Y, Bai LH, Zhang LD.
    World J Gastroenterol; 2015 Jun 07; 21(21):6649-59. PubMed ID: 26074703
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic value of serum squamous cell carcinoma antigen for hepatocellular carcinoma: a systematic review and meta-analysis.
    Yu J, Wang ZJ, Chen LH, Dong WZ.
    Scand J Clin Lab Invest; 2017 Feb 07; 77(1):8-14. PubMed ID: 27762143
    [Abstract] [Full Text] [Related]

  • 20. Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study.
    Biasiolo A, Trotta E, Fasolato S, Ruvoletto M, Martini A, Gallotta A, Fassina G, Angeli P, Gatta A, Pontisso P.
    Dig Liver Dis; 2016 Feb 07; 48(2):197-202. PubMed ID: 26614642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.